n INTRODUCTION F ibromyalgia (FM)/fibromyalgia syndrome (FMS) is still a controversial condition, because of social and community consequences, as well as disputes about etiology and pathogenesis (1, 2) . The aims of the present paper are as follows: -to give an overview on the different validated diagnostic criteria of FMS; -to point out some open questions in diagnosing FMS; -to outline a diagnostic work-up for patients with fibromyalgia type symptoms in primary care; -to discuss the role of rheumatologists and mental health specialists in the diagnostic process.
n METHODS
We performed a narrative review of the literature on diagnosis of FMS. Our recommendations are based on consensus documents by the American College of Rheumatology (ACR) and by the evidencebased interdisciplinary German guidelines on the diagnosis and management of FMS.
American College of Rheumatology (ACR) 1990 criteria
The number of tender points necessary for FM-diagnosis was investigated in the 1990 FM-criteria study (3) . To manage examiner heterogeneity, training sessions were undertaken in order to have the 22 study physicians examining patients in the same way. In addition, it was settled that 4 kg be the REVIEW Diagnosis and diagnostic tests for fibromyalgia (syndrome) amount of force exerted by the palpating finger or thumb. In unpublished data from the criteria study, we noted that prior to the training session different examiners used substantially different amounts of force, but that even though examiner variance decreased during the study it was still quite noticeable. That is, even among trained experts there was considerable variability in the performance of the tender point examination. With this as background, a consortium of investigators undertook a criteria study that would ultimately lead to the promulgation of the 1990 ACR classification criteria for FM. A team of 22 rheumatologists served as volunteer investigators. Each contributed from their practice 10 patients with FM, 10 with FM and rheumatoid arthritis, osteoarthritis or axial pain syndromes, 10 patients who did not have FM but other rheumatic conditions involving pain (e.g. osteoarthritis, low back pain), and the last 10 who were patients with rheumatoid arthritis, osteoarthritis or axial pain syndromes without FM. Each patient underwent a tender point examination that included many tender point sites, comprising those known not to be sensitive to pressure. In addition, patients were evaluated for different symptoms of FM, including those of the Yunus criteria (4). Investigators underwent a training session so that the tender point examination was performed the same way by each investigator.
The preliminary ACR 2010 criteria
These were developed in an US multicenter study of 829 previously diagnosed FM-patients and controls using physician physical and interview examinations by 10 rheumatologists, including a widespread pain index (WPI), a measure of the number of painful body regions. Random forest and recursive partitioning analyses were used to guide the development of a case definition of fibromyalgia, to develop criteria, and to construct a symptom severity (SS) scale (5) .
The Fibromyalgia Survey Diagnostic Criteria (FSDC): these were established in a longitudinal study of patients of the Na- Levels of evidence were assigned according to the classification system of the Oxford-Centre for Evidence Based Medicine. The strength of recommendations was built by multiple step formal procedures to reach a consensus. The guidelines were reviewed by the board of directors of the societies engaged in the development of the guidelines (8) . Recommendations regarding the classification and diagnosis of FMS were based on expert consensus (9) .
n RESULTS
Pre-ACR diagnostic criteria
FM and fatigue-like illnesses were identified as early as the nineteenth century, and sporadic descriptions of FM can be found through the 1960s. The modern concept of FMS arose in the 1970s to characterize a common group of patients, mostly middle-aged women, who had high levels of pain, multiple complaints, sleep disturbance, psychiatric symptoms, and a generally decreased threshold to painful stimuli (2) . Such patients are common in general medicine and represent about 2-4% of the general European population (10). 
The 1990 classification criteria
Based on comparing patients with similar but non-fibromyalgia pain complaints, the ACR-committee found that the presence of widespread pain combined with at least 11 of 18 tender points best separated patients with fibromyalgia and controls, even though some combinations of symptoms (e.g., fatigue, cognitive problems) were not evaluated (3). This occurred because the authors did not recognize the importance of these symptoms at the time of the study. The authors suggested that the presence of 11 of 18 tender points and the simultaneous presence of WSP for at least 3 months should be the classification criteria for FM (3) ( Table I) . Initially intended for research purposes, the criteria were later widely used in clinical diagnosis, particularly among rheumatologists; they were also used in basic science Table I -The 1990 American College of Rheumatology criteria for the fibromyalgia classification (3).
History of widespread pain
Definition. Pain is considered widespread when all of the following are present: -pain in the left side of the body, -pain in the right side of the body, -pain above the waist, -pain below the waist. In addition, axial skeletal pain (cervical spine or anterior chest or thoracic spine or low back) must be present. In this definition, shoulder and buttock pain is considered as pain for each involved side. 'Low back' pain is considered lower segment pain.
Pain in 11 of 18 tender point sites on digital palpation
Definition. Pain on digital palpation must be present at least in 11 of the following 18 sites: -Occiput: Bilateral, at the suboccipital muscle insertions.
-Low cervical: bilateral, at the anterior aspects of the intertransverse spaces at C5-C7.
-Trapezius: bilateral, at the mid-point of the upper border.
-Supraspinatus: bilateral, at origins, above the scapula spine near the medial border.
-Second rib: bilateral, at the second costochondral junctions, just lateral to the junctions on upper surfaces. -Lateral epicondyle: bilateral, 2 cm distal to the epicondyles.
-Gluteal: bilateral, in upper outer quadrants of buttocks in anterior fold of muscle.
-Greater trochanter: bilateral, posterior to the trochanteric prominence.
-Knee: bilateral, at the medial fat pad proximal to the joint line. Digital palpation should be performed with an approximate force of 4 kg.
REVIEW
Diagnosis and diagnostic tests for fibromyalgia (syndrome) and clinical studies. The endorsement by the ACR aided in establishing FM as a respectable clinical diagnosis.
Criticism of the 1990 criteria items
Numerous concerns were raised on the reliability and validity of the tender point examination (TPE) when used for diagnosis of FMS in the disability setting, which led to the recommendation to stop their use in the clinic (12) . a) A standardized manual tender point survey was developed (13) , but this protocol was almost never used by rheumatologists in clinical practice, and was used only in a few clinical studies. b) The tender point count was shown to be influenced by the interaction between patient and examiner and was highly correlated with distress (14) . c) The tender point count was a poor marker of change in clinical studies.
d) The reliability and validity of the TP examination outside the context of FMSspecialized rheumatology settings was never tested. e) FMS is not a disorder diagnosed and treated by rheumatologists exclusively.
Patients are also diagnosed and treated by general practitioners, pain specialists, or mental health specialists. TPE is largely ignored in these settings. Nonrheumatologists had not been trained for TPE within their residency program. Moreover, TPE would be time consuming in these settings. Even if a competent physician of whatever discipline who is able to conduct a thorough medical examination could be taught a standardized manual TPE, the time to carry out this examination could be used to extract a more comprehensive psychosocial history. f) Although increased tenderness or hy- W. Häuser, F. Wolfe REVIEW peralgesia/allodynia to pressure stimuli had been replicated by other more objective ways of assessment, its relevance and specificity for the diagnosis of FMS had been questioned (15) . g) Chronic widespread pain (CWP) and tender points do not capture other key symptoms such as fatigue and sleeping problems (16) .
American College of Rheumatology 2010 preliminary diagnostic criteria
The 2010 criteria (Table II) addressed a number of problems with the 1990 criteria. They eliminated the TPE, a physical examination item, replaced by the widespread pain index (WPI), a 0-19 count of the number of body regions reported as painful by the patient. In addition, the 2010 criteria assessed on a 0-3 severity scale a series of symptoms that were characteristic of fibromyalgia: fatigue, non-refreshed sleep, cognitive problems, and the extent of somatic symptom reporting. The items were combined into a 0-12 Symptom Severity (SS) scale. Finally, the Widespread Pain Index (WPI) and SS-scales could be combined into a 0-31 fibromyalgianess scale, a second measure of polysymptomatic distress or FM severity (3). The criteria committee considered that the diagnosis of a symptom severity disorder should require more than an 'augenblick' diagnosis. Instructions, a criteria worksheet, and a patient pain location report are available on-line as an aid to ACR2010 assessments (www.arthritis-research.org/ research/fibromyalgia-criteria).
Survey diagnostic criteria
The 2010 criteria imposed some burdens on the examiner. The SS-scale items re- (6) . The FSQ can be used to assist medical diagnosis. The interpretation and assessment of questionnaire's validity, however, must be the work of the physician. Selfdiagnosis of FMS based only on the FSQ is not allowed. The use of questionnaires for screening purposes and assisting diagnoses is common in psychiatry, psychology and pain medicine, and can be applied to primary care, too.
n OPEN QUESTIONS

Fibromyalgia or fibromyalgia syndrome?
The endorsement of the classification criteria of "fibromyalgia" by the ACR brought official recognition to the term. "Fibromyalgia" received an International Classification of Disease (ICD) code by the World Health Organization and is included into the diseases of the (ICD M 79.7). "Fibromyalgia" is listed in the International Classification of Diseases of the World Health Organisation within Chapter M "Diseases of the musculoskeletal system and connective tissue" with the code M 79.7 (17) . The German guideline recommends the use of the term "fibromyalgia syndrome" rather than "fibromyalgia" to preclude confusion with a distinct somatic (rheumatology) disease (9), as there is no clear evidence of a structural organ damage underlying FMS-symptoms (18) . A syndrome is defined to be a group of symptoms that collectively indicate or characterize a disease, psychological disorder, or other abnormal condition. Based on the currently available evidence, FMS is classified to be a first rank syndrome (unknown etiology, heterogenous pathogenesis and defined phenotype) (19) . FMS may be classified as a functional somatic syndrome -defined by a typical group of symptoms and the exclusion of a somatic disease sufficiently explaining the symptoms (9).
How to assess CWP?
Despite all controversies, there is an agreement between most clinicians, that CWP is one main clinical feature of FMS. In the clinics, CWP can be assessed by a pain diagram (blank body manikin) filled out by the patient (Figures 1 and 2 ). For the busy clinician, the most frequently used definitions of CWP can be cumbersome to use. The ACR 1990 criteria define CWP to be pain in the left side of the body, pain in the right side of the body, pain above the waist, and pain below the waist; axial skeletal pain (cervical spine or anterior chest or thoracic spine or low back). In this definition, shoulder and buttock pain is considered as pain for each involved side. 'Low back' pain is considered lower segment pain (5 (20) . The criteria of pain in 3 or more segments of the body quadrant (21) or of pain axially and in all 4 extremities (22) are more intuitive. Many patients report and mark a pain "all over" in the manikin (Figure 2 ). In these cases, every criterion of CWP is met. Alternatively, the patient can complete the WPI. WSP is defined by ≥7/19 pain sites (6) . In a German multicenter study including different specialties the concordance rate between the ACR 1990 and WPI-criteria of WP (≥7/19 pain sites) was 100% (22) . The important point at a clinical level is to identify patients with CWP.
Different diagnostic criteria for FMSdoes it matter?
The concordance rate of the ACR 1990 classification criteria with the "Katz" criteria, an ancestor of the FSDC, was 72% in an US American rheumatology practice (23) and 80% in a German study including different specialties (21) . The concordance rate between the ACR 1990 and FSDCcriteria was 73% in subsample of 128 patients (7). As with CWP-definitions, patients with high levels of polysymptomatic distress (high levels of bodily and psychological symptoms) will meet all FMS-criteria. Whether the preliminary ACR 2010 or the FSDC -criteria will lead to change in the prevalence of FMS or to a change of the clinical features of the FMS-populations still needs to be determined. Preliminary data suggest that FMS may be more frequently diagnosed in men by the new diagnostic criteria than the old, because they tender point criterion was one reason which led to a preponderance of women in the FMS-population (24) . In CWP, most epidemiology studies found an equal gender distribution (25) .
Incomplete FMS?
Whatever diagnostic criteria are used, there will always be some patients left who do not meet the "FMS-positive" criterion at the time of the examination. In the ACR 2010 criteria study, 25% of previously di- agnosed FMS patients did not meet criteria (5) . In a single center study of an US rheumatology clinic, 18.7% of the patients previously diagnosed with FMS did not meet the ACR 1990 criteria of FMS. These patients were labeled "incomplete FMS (IFMS)". IFMS-patients reported less frequent and severe symptoms than FMSpatients (26) . This study highlights the usefulness of conceptualizing FMS to be the end of the spectrum of biopsychosocial distress (14, 27, 28) , and to use continuous scales such as the WPI and SSS to assess symptom-burden in patients instead of classifying patients FMS-positive or negative. Using the IFMS definition, potentially everyone has IFMS.
Assessing the severity of FMS
While the ACR 2010 criteria case definition of fibromyalgia implies a general homogeneity in core symptoms (degree of WSP, fatigue, cognitive, sleep problems, and excess somatic symptom reporting), FMS remains a complex of various symptoms: Patients differ in the amount of somatic and psychological symptoms, disability, coping and associated psychosocial problems (17) . Generally accepted severities of FMS are not available. Approaches to grading fibromyalgia severity include use the ACR 2010 Symptom Severity Scale (3) and the Polysymptomatic Distress Scale (or Fibromyalgianess Scale) (6) . The Fibromyalgia Impact Questionnaire (FIQ)-Revised total scores (29) has been used to define FM severity, with 0-<39, 39-<59, and 59-100, representing mild, moderate, and severe FM, respectively (30) .
FMS and somatic disease?
The ACR 1990 classification study concluded that the diagnosis of FMS can be accomplished with confidence even in the presence of other medical conditions (3). Most notably the "other medical conditions" assessed in this study were rheumatic diseases such as rheumatoid arthritis, osteoarthritis, and low back and neck pain syndromes, but not other internal or neurology diseases which can present with widespread pain. The study results have not been tested in such settings. The prevalence-rates of FMS in diseases with structural (organic) damages had been found to range between 12-20% in rheumatoid arthritis, 5-25% in Lupus erythematosus, 11-50% in ankylosing spondylitis, 17-18% in diabetes mellitus and 3-49% in inflammatory bowel diseases (31) . In fact, in every somatic disease patients with high levels of psychosocial distress which can be labelled "FM" can be identified (32) . The preliminary ACR 2010 criteria require that the fibromyalgia diagnosis be excluded in the presence of a somatic disease which could sufficiently explain the symptoms (5) . Not infrequently FMS occurs in patients with other diseases. In such a situation the physician can diagnose both disorders. A problem arises when the "other" disease has signs and/or symptoms similar to those found in FMS, leading to believe that FMS is present when it is not. A patient with extensive burns would have many tender points and WSP. Though satisfying ACR 1990 criteria, we would not be able to diagnose FMS in such a patient. The situation is more complex (and realistic) when we consider diseases like metastatic cancer. In such a situation the patient might satisfy FMS criteria by virtue of cancer or of FMS, or of both. A comprehensive history, physical examination and appropriate screening test most often would clarify the issue. The physician could choose to diagnose one or both disorders, depending on clinical judgment. In population studies that use the FDSC the existence of other diseases may not be known. Because of this, FMS could be over-diagnosed and the apparent prevalence inflated. But such disorders are uncommon. Their actual importance would depend on the prevalence of the underlying disorder multiplied by the proportion with that disorder which has fibromyalgia signs and symptoms caused only by that disorder. The net effect would be very small.
Do we need FMS-screening tools?
In our opinion, no FMS-screening tools are necessary in general medicine, rheumatology and pain medicine practice. In these (Table IV) .
Physical examination
The patients suspected of having FMS should have a complete physical examination, including an orthopedic and neurological examination.
Blood tests and diagnostic imaging
Numerous somatic diseases can lead to CWP, fatigue and sleep disturbances (35) (Table V) and that these symptoms can be relieved by medical treatment.
The following routine blood tests are recommended for patients with CWP (potential differential diagnosis or concomitant diagnoses are indicated in brackets): a) Blood sedimentation rate, C-reactive protein, red and white cell blood count (polymyalgia rheumatica, rheumatoid arthritis). b) Creatinin kinase (muscle disease). c) Calcium (hypercalcaemia). d) Thyroid-stimulating hormone (hypothyroidism). e) Depending on history and examination further blood tests can be necessary if other differential diagnoses are suspected. Without clinical signs, routine testing for antibodies associated with rheumatoid dis- 
Referral to specialists
In case of a suspected internal, neurological or orthopaedic disease (partially explaining the symptoms) referral to a specialist is recommended. Tests profiles for concomitant internal diseases have been described (36) .
Final diagnosis
In a report, physicians should detail the criteria used (ACR 1990 , ACR 2010 Over the last 2 weeks, have you been bothered by the following problems? -Feeling nervous, anxious or on edge (Anxiety). -Not being able to stop or control worrying (Anxiety).
-Little interest or pleasure in doing things (Depression). -Feeling down, depressed, or hopeless (Depression). The amount of additional somatic and psychological symptoms, psychosocial problems and limitations of daily activities can help to grade the severity of FMS. Patients with positive screens for anxiety and/or depression, severe restrictions of daily functions and severe psychosocial problems should be referred to a metal health specialist (psychosomatic medicine, clinical psychology, psychiatry) (38) . n CONCLUSIONS Should rheumatologists by the primary physician for FMS (39)? A survey of 600 patients in six European countries, South Korea and Mexico demonstrated that the specialties initially contacted for FMSsymptoms and for long-term treatment were quite variable across countries (40) . The new diagnostic criteria do not require a rheumatologist to perform TPE. The diagnosis of FMS is easy to establish in most patients with CWP and no signs of a somatic disease as cause of CWP. A rheumatologist's expertise might be needed to exclude difficult to diagnose or concomitant inflammatory rheumatic diseases. Given the high rate of comorbid functional somatic syndromes and mental disorders in FMS (41), a mental health specialist's evaluation (38) . By which specialties FMS-patients will be treated in the long-term, it can depend on the type of health care system and the individual preferences of the physicians.
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